[DOC][DOC] The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations

ND Mdege, N Meader, C Lloyd… - Public Health …, 2017 - eprints.whiterose.ac.uk
Background: Whilst illegal drug use has, largely, been declining in the UK over the past
decade, this period has witnessed the emergence of a range of novel psychoactive …

A market on both “sides” of the law: The use of the hidden web for the sale of new psychoactive substances

E Wadsworth, C Drummond… - Human …, 2017 - Wiley Online Library
Abstract Objective The hidden Web is used for the anonymous sale of drugs, and with the
UK Psychoactive Substances Act, 2016, implemented on May 26th 2016; it could increase …

Recent use of synthetic cannabinoids, synthetic opioids, and other psychoactive drug groups among high-risk drug users

B Shapira, R Berkovitz, P Rosca… - Journal of psychoactive …, 2020 - Taylor & Francis
The use of synthetic cannabinoids receptor agonists (SCRA) and synthetic opioids is
associated with significant morbidity and mortality. This study examined the patterns-of-use …

Impact of synthetic cannabinoids on the duration of opioid‐related withdrawal and craving among patients of addiction clinics in K azakhstan: A prospective case …

M Prilutskaya, FS Bersani, O Corazza… - Human …, 2017 - Wiley Online Library
Objective The aim of the study was to prospectively assess whether regular use of synthetic
cannabinoids (SCs) affects the duration of opioid‐related withdrawal and craving symptoms …

[PDF][PDF] Sociodemographic and clinical features of young adult males using synthetic cannabinoid

T Öznur, H Öznur, A Bolu, C Çelik… - Turkish J Clinical …, 2018 - jag.journalagent.com
SUMMARY Object: Synthetic Cannabinoid (SC) use is becoming more widespread
throughout the world. Studies that revealed user profiles indicate that the drug is especially …

[PDF][PDF] Research Portfolio Submitted in Part Fulfilment of the requirements for the Degree of Doctorate in Clinical Psychology Volume 1 of 2

A Austin - 2023 - researchportal.bath.ac.uk
Background About a third of people use drugs during their incarceration, which is associated
with multiple adverse health and criminal justice outcomes. Many studies have examined …

Novel psychoactive substances: A new challenge for prevention and treatment.

M Kapitány-Fövény, O Corazza, S Marrinan… - 2020 - psycnet.apa.org
The significant shift on how drugs are now manufactured, marketed, sold and consumed,
driven by technological development and by globalization, has raised major challenges in …

PSYCHIATRIC MANIFESTATIONS IN PATIENTS ADDICTED TO A NEW SYNTHETIC PSYCHOACTIVE SUBSTANCE (STROCKS)

A Abdo Mohamed El-Shahawy… - Al-Azhar Medical …, 2022 - journals.ekb.eg
Background: Substance abuse is a growing problem in the world. In Egypt, as in many
developing countries, substance abuse is a growing problem that worries both people and …

Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications

M Prilutskaya, JC Yang… - Handbook of Novel …, 2018 - taylorfrancis.com
In Chapter 10,“Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications”,
Mariya Prilutskaya, Justin C. Yang, and Andres Roman-Urrestarazu discuss synthetic …

Оценка риска прекращения лечения у пациентов с зависимостью от новых психоактивных веществ

МВ Прилуцкая, АС Ракишева… - Наука о жизни и …, 2019 - cyberleninka.ru
Основным индикатором эффективности терапии наркологических расстройств
является удерживаемость пациентов в программах реабилитации. Появление новых …